Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1993 1
1994 1
2004 1
2005 2
2007 2
2008 3
2009 1
2010 2
2011 1
2012 6
2013 4
2014 7
2015 5
2016 3
2017 6
2018 7
2019 8
2020 2
2021 6
2022 4
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Inker LA, Collier W, Greene T, Miao S, Chaudhari J, Appel GB, Badve SV, Caravaca-Fontán F, Del Vecchio L, Floege J, Goicoechea M, Haaland B, Herrington WG, Imai E, Jafar TH, Lewis JB, Li PKT, Maes BD, Neuen BL, Perrone RD, Remuzzi G, Schena FP, Wanner C, Wetzels JFM, Woodward M, Heerspink HJL; CKD-EPI Clinical Trials Consortium. Inker LA, et al. Among authors: goicoechea m. Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17. Nat Med. 2023. PMID: 37330614
In an analysis of individual participant data, for each of 66 studies (total of 186,312 participants), we estimated treatment effects on the total GFR slope, computed from baseline to 3 years, and chronic slope, starting at 3 months after randomization, and on the clinical endpoi …
In an analysis of individual participant data, for each of 66 studies (total of 186,312 participants), we estimated treatment effects on the …
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Larrayoz M, Garcia-Barchino MJ, Celay J, Etxebeste A, Jimenez M, Perez C, Ordoñez R, Cobaleda C, Botta C, Fresquet V, Roa S, Goicoechea I, Maia C, Lasaga M, Chesi M, Bergsagel PL, Larrayoz MJ, Calasanz MJ, Campos-Sanchez E, Martinez-Cano J, Panizo C, Rodriguez-Otero P, Vicent S, Roncador G, Gonzalez P, Takahashi S, Katz SG, Walensky LD, Ruppert SM, Lasater EA, Amann M, Lozano T, Llopiz D, Sarobe P, Lasarte JJ, Planell N, Gomez-Cabrero D, Kudryashova O, Kurilovich A, Revuelta MV, Cerchietti L, Agirre X, San Miguel J, Paiva B, Prosper F, Martinez-Climent JA. Larrayoz M, et al. Among authors: goicoechea i. Nat Med. 2023 Mar;29(3):632-645. doi: 10.1038/s41591-022-02178-3. Epub 2023 Mar 16. Nat Med. 2023. PMID: 36928817 Free PMC article.
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
Botta C, Perez C, Larrayoz M, Puig N, Cedena MT, Termini R, Goicoechea I, Rodriguez S, Zabaleta A, Lopez A, Sarvide S, Blanco L, Papetti DM, Nobile MS, Besozzi D, Gentile M, Correale P, Siragusa S, Oriol A, González-Garcia ME, Sureda A, de Arriba F, Rios Tamayo R, Moraleda JM, Gironella M, Hernandez MT, Bargay J, Palomera L, Pérez-Montaña A, Goldschmidt H, Avet-Loiseau H, Roccaro A, Orfao A, Martinez-Lopez J, Rosiñol L, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Martinez Climent JA, Paiva B; Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) cooperative group; iMMunocell study group. Botta C, et al. Among authors: goicoechea i. Nat Commun. 2023 Sep 20;14(1):5825. doi: 10.1038/s41467-023-41562-6. Nat Commun. 2023. PMID: 37730678 Free PMC article.
Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN).
Rojas-Rivera JE, García-Carro C, Ávila AI, Espino M, Espinosa M, Fernández-Juárez G, Fulladosa X, Goicoechea M, Macía M, Morales E, Quintana LF, Praga M. Rojas-Rivera JE, et al. Among authors: goicoechea m. Clin Kidney J. 2023 Mar 22;16(9):1384-1402. doi: 10.1093/ckj/sfad055. eCollection 2023 Sep. Clin Kidney J. 2023. PMID: 37664575 Free PMC article. Review.
N-Heterocyclic carbene-stabilised arsinidene (AsH).
Doddi A, Weinhart M, Hinz A, Bockfeld D, Goicoechea JM, Scheer M, Tamm M. Doddi A, et al. Among authors: goicoechea jm. Chem Commun (Camb). 2017 Jun 1;53(45):6069-6072. doi: 10.1039/c7cc02628e. Chem Commun (Camb). 2017. PMID: 28466884
Aluminium and Gallium Silylimides as Nitride Sources.
Heilmann A, Saddington AM, Goicoechea JM, Aldridge S. Heilmann A, et al. Among authors: goicoechea jm. Chemistry. 2023 Nov 24;29(66):e202302512. doi: 10.1002/chem.202302512. Epub 2023 Oct 12. Chemistry. 2023. PMID: 37604785
Terminal aluminium and gallium imides of the type K[(NON)M(NR)], bearing heteroatom substituents at R, have been synthesised via reactions of anionic aluminium(I) and gallium(I) reagents with silyl and boryl azides (NON=4,5-bis(2,6-diisopropyl-anilido)-2,7-di-tert-butyl-9, …
Terminal aluminium and gallium imides of the type K[(NON)M(NR)], bearing heteroatom substituents at R, have been synthesised via reac …
Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C, Sánchez E, Cano C, Jagerovic N, Martín MI. Goicoechea C, et al. Eur J Pharmacol. 2008 Oct 24;595(1-3):22-9. doi: 10.1016/j.ejphar.2008.07.052. Epub 2008 Jul 31. Eur J Pharmacol. 2008. PMID: 18706410
We previously reported the synthesis of three new opioid agonists as well as their in vitro and in vivo activity [Giron, R., Abalo, R., Goicoechea, C., Martin, M.I., Callado, L.F., Cano, C., Goya, P., Jagerovic, N. 2002. Synthesis and opioid activity of new fentanyl analog …
We previously reported the synthesis of three new opioid agonists as well as their in vitro and in vivo activity [Giron, R., Abalo, R., Goic …
Body composition and ventricular function in hemodialysis patients.
Carbayo J, Abad S, Verde E, Muñoz de Morales A, Gonzalez-Rojas A, Acosta A, Mijaylova A, Bascuñana A, Vega A, Goicoechea M. Carbayo J, et al. Among authors: goicoechea m. Semin Dial. 2021 Jul;34(4):285-291. doi: 10.1111/sdi.12955. Epub 2021 Feb 20. Semin Dial. 2021. PMID: 33609406
The mean follow-up time was 30.6 months. Patients who had a higher fat tissue index (FTI > 9.20 kg/m(2) ) experienced a worsening in right and left ventricular function. ...
The mean follow-up time was 30.6 months. Patients who had a higher fat tissue index (FTI > 9.20 kg/m(2) ) experienced a worsening …
Probing the Extremes of Covalency in M-Al bonds: Lithium and Zinc Aluminyl Compounds.
Roy MMD, Hicks J, Vasko P, Heilmann A, Baston AM, Goicoechea JM, Aldridge S. Roy MMD, et al. Among authors: goicoechea jm. Angew Chem Int Ed Engl. 2021 Oct 4;60(41):22301-22306. doi: 10.1002/anie.202109416. Epub 2021 Sep 1. Angew Chem Int Ed Engl. 2021. PMID: 34396660
Comparison with magnesium and zinc aluminyl systems reveals changes to both the M-Al bond and the (NON)Al fragment (where NON=4,5-bis(2,6-diisopropylanilido)-2,7-di-tert-butyl-9,9-dimethylxanthene), consistent with a more covalent character, with the latter complex being s …
Comparison with magnesium and zinc aluminyl systems reveals changes to both the M-Al bond and the (NON)Al fragment (where NON=4,5-bis …
71 results